New Therapy for Rare Lymphoma
A drug called mogamulizumab significantly improved progression-free survival for patients with cutaneous T-cell lymphoma, according to a study published in The Lancet Oncology.
Browsing: Clinical Breakthroughs
New Advances in Heart Failure Treatment
Northwestern Medicine scientists demonstrated the efficacy of novel treatments for heart failure and provided new insights into mechanisms of the disease, in three recent studies.
Genomic Autopsy Can Help Solve Unexplained Cardiac Death
Molecular autopsies can reveal genetic risk factors in young people who unexpectedly die, but proper interpretation of the results can be challenging, according to a recent study.
Induced Labor at 39 Weeks Reduces Need for Cesarean Birth
A large national study shows electively inducing labor at 39 weeks actually reduces the rate of cesarean deliveries and decreases maternal and fetal complications.
Prompt Treatment Improves Outcomes in Pediatric Sepsis
Pediatric patients with sepsis who completed a series of treatments within one hour of sepsis recognition had better outcomes, according to a new multi-center study.
Exploring Intervention to Improve Medication Self-Management
EHR-based tools designed to help patients manage complex drug regimens failed to improve medication adherence or lower blood pressure among patients with hypertension, according to a Northwestern Medicine study.
Rethinking Longstanding Treatment for Diabetes Complications
Children with a rare complication of diabetes may not need fluid administered slowly, in contrast to current treatment guidelines, according to a study published in the New England Journal of Medicine.
Policy Expert
Lori Post, director of Feinberg’s Buehler Center for Health Policy and Economics, takes a high-level approach to protect worldwide victims of abuse, neglect and exploitation.
Coffee Consumption Linked to Lower Risk of Death
Drinking coffee is associated with a lower risk of death, according to a large study published in JAMA Internal Medicine.
Clinical Trials Show Promise in Leukemia
Two drugs that target mutations in leukemia showed encouraging results, according to recent clinical trials.